Sun-Edelstein, Christina http://orcid.org/0000-0002-6192-0527
Rapoport, Alan M. http://orcid.org/0000-0002-6311-8562
Rattanawong, Wanakorn
Srikiatkhachorn, Anan http://orcid.org/0000-0003-1592-8541
Article History
Accepted: 15 April 2021
First Online: 17 May 2021
Declarations
:
: None.
: Dr Sun-Edelstein is on the Migraine Advisory Boards for Teva, Eli Lilly, and Lundbeck. She has also received speaking fees from Teva and Eli Lilly. Compliance with Ethical Standards statement: “I am on the migraine advisory board for Teva, Eli Lilly, and Lundbeck pharmaceutical companies and have received speaking fees from Teva and Eli Lilly. Discussion of their medications in this manuscript is primarily based on data that has been published or presented at conferences. Any description of my experiences with these medications is clearly specified as such and is not influenced by any role I have with these companies.” Prof. Rapoport has received consulting fees or honoraria from Allergan, Amgen, Biohaven, Cala Health, Novartis, Satsuma, Teva Pharmaceutical Industries, Theranica, Xoc, and Zosano. He has also received speaking fees from Allergan, Amgen Biohaven, Lundbeck, and Teva Pharmaceutical Industries. Compliance with Ethical Standards statement: “I have consulted for and have been part of the Speakers Bureau for multiple companies. Any mention of clinical data from any of those companies is purely an accurate representation of that data. Any mention of how I use a medication is the honest representation of how I would use it whether or not I was a consultant or speaker for the company.” Dr Rattanawong does not have anything to disclose. Prof. Srikiatkhachorn does not have anything to disclose.
: N/A.
: N/A.
: N/A.
: N/A.
: N/A.
: Article conceptualization: AR, AS, CSE. Writing: Original draft preparation (CSE, AS), review and editing (AR, CSE, AS, WR).